Live Breaking News & Updates on Fosun Diagnostics

Stay updated with breaking news from Fosun diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

/PRNewswire/ April 13, 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH, 02196.HK) announced that. ....

United States , Fosun Pharma , Council Of China , Sinopharm Co Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , European Union , Solutions For Covid , Eu Health Security Committee Common List , Security Committee Common List , State Council , Joint Prevention , Coronavirus Antigen Detection Application Plan , Pilot Trial , Independent Innovation , Providing Comprehensive Solutions , Fosun Diagnostics , Novel Coronavirus , Registration Certificate , Medical Device , Diagnostic Novel Coronavirus Detection Kit , Shanghai Fosun Pharmaceutical ,

Fosun Diagnostics Obtains China Approval for SARS-CoV-2 Antigen Test

The kit detects the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs within seven days of infection for patients with respiratory and fever symptoms. ....

Fosun Pharma , China National Medical Products Administration , European Union , Institute For Drugs , Shanghai Fosun Pharmaceutical , National Medical Products Administration , Fosun Diagnostic , Novel Coronavirus , Antigen Detection Kit , Colloidal Gold , Fosun Diagnostics , Federal Institute , Medical Devices , Fosun Diagnostic Novel Coronavirus ,

Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively

The Proportion of Revenue from Innovative Products Continues to Increase Highlights: Revenue for the year ended December 31, 2021 was RMB39,005 million,. ....

South Sudan , United States , Hong Kong , Han Li Kang Rituximab , Yi Bao , Wanbang Biopharm , Yao Pharma , Wu Yifang , Fosun Pharma , Axicabtagene Ciloleucel , Guilin Pharma , Xin Avatrombopag , Han Li Kang , Sinopharm Co Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , Vaccines Division , Innovation For Good Health , Innovative Medicines Division , National Medical Products Administration , Medicines Manufacturing Supply Division , Rating Expert Committee , Innovative Products Continues , Mainland China , Han Qu You , Shanghai Fosun Pharmaceutical , Stock Code ,